{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:37:26Z","timestamp":1790620646669,"version":"4.1.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10349-8","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:12:20Z","timestamp":1781331140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1921-1336","authenticated-orcid":false,"given":"Maria A.","family":"Papanikolaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-6409","authenticated-orcid":false,"given":"Antonios N.","family":"Gargalionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-4216","authenticated-orcid":false,"given":"Christos","family":"Adamopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-0618","authenticated-orcid":false,"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"10349_CR1","volume-title":"Neonatal brain tumors","author":"T Karsonovich","year":"2025","unstructured":"Karsonovich, T., & Ahmad, T. (2025). Neonatal brain tumors. StatPearls Publishing."},{"key":"10349_CR2","unstructured":"Louis, D. N., Pfister, S. M., Perry, A., Ellison, D. W., von Deimling, A., Reifenberger, G., Figarella-Branger, D., Brat, D. J., & Hawkins, C. (n.d.). Gliomas, glioneuronal tumours, and neuronal tumours: Introduction. BlueBooksOnline. Retrieved January 11, 2026, from https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/45\/216"},{"issue":"1","key":"10349_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/acschemneuro.7b00388","volume":"9","author":"AY Mochizuki","year":"2018","unstructured":"Mochizuki, A. Y., Frost, I. M., Mastrodimos, M. B., Plant, A. S., Wang, A. C., Moore, T. B., Prins, R. M., Weiss, P. S., & Jonas, S. J. (2018). Precision medicine in pediatric neurooncology: A review. ACS Chemical Neuroscience, 9(1), 11\u201328. https:\/\/doi.org\/10.1021\/acschemneuro.7b00388","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"10349_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.meddos.2018.06.008","volume":"44","author":"T Wang","year":"2019","unstructured":"Wang, T., Manohar, N., Lei, Y., Dhabaan, A., Shu, H.-K., Liu, T., Curran, W. J., & Yang, X. (2019). MRI-based treatment planning for brain stereotactic radiosurgery: Dosimetric validation of a learning-based pseudo-CT generation method. Medical Dosimetry, 44(3), 199\u2013204. https:\/\/doi.org\/10.1016\/j.meddos.2018.06.008","journal-title":"Medical Dosimetry"},{"issue":"4","key":"10349_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/children9040498","volume":"9","author":"K Lutz","year":"2022","unstructured":"Lutz, K., J\u00fcnger, S. T., & Messing-J\u00fcnger, M. (2022). Essential management of pediatric brain tumors. Children, 9(4), Article 498. https:\/\/doi.org\/10.3390\/children9040498","journal-title":"Children"},{"issue":"2","key":"10349_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-022-04049-w","volume":"159","author":"A-L Luger","year":"2022","unstructured":"Luger, A.-L., K\u00f6nig, S., Samp, P. F., Urban, H., Div\u00e9, I., Burger, M. C., Voss, M., Franz, K., Fokas, E., Filipski, K., Demes, M.-C., Stenzinger, A., Sahm, F., Reuss, D. E., Harter, P. N., Wagner, S., Hattingen, E., Wichert, J., Lapa, C., & Ronellenfitsch, M. W. (2022). Molecular matched targeted therapies for primary brain tumors\u2014A single center retrospective analysis. Journal of Neuro-Oncology, 159(2), 243\u2013259. https:\/\/doi.org\/10.1007\/s11060-022-04049-w","journal-title":"Journal of Neuro-Oncology"},{"issue":"7216","key":"10349_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"McLendon, R., Friedman, A., Bigner, D., Van Meir, E. G., Brat, D. J., Mastrogianakis, G. M., Olson, J. J., Mikkelsen, T., Lehman, N., Aldape, K., Yung, W. K. A., Bogler, O., VandenBerg, S., Berger, M., Prados, M., Muzny, D., Morgan, M., Scherer, S., Sabo, A., \u2026 The Cancer Genome Atlas Research Network","year":"2008","unstructured":"McLendon, R., Friedman, A., Bigner, D., Van Meir, E. G., Brat, D. J., Mastrogianakis, G. M., Olson, J. J., Mikkelsen, T., Lehman, N., Aldape, K., Yung, W. K. A., Bogler, O., VandenBerg, S., Berger, M., Prados, M., Muzny, D., Morgan, M., Scherer, S., Sabo, A., \u2026 The Cancer Genome Atlas Research Network. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061\u20131068. https:\/\/doi.org\/10.1038\/nature07385","journal-title":"Nature"},{"issue":"5","key":"10349_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ijc.30828","volume":"141","author":"P Horak","year":"2017","unstructured":"Horak, P., Klink, B., Heining, C., Gr\u00f6schel, S., Hutter, B., Fr\u00f6hlich, M., Uhrig, S., H\u00fcbschmann, D., Schlesner, M., Eils, R., Richter, D., Pf\u00fctze, K., Ge\u00f6rg, C., Mei\u00dfburger, B., Wolf, S., Schulz, A., Penzel, R., Herpel, E., Kirchner, M., \u2026 Fr\u00f6hling, S. (2017). Precision oncology based on omics data: The NCT Heidelberg experience. International Journal of Cancer, 141(5), 877\u2013886. https:\/\/doi.org\/10.1002\/ijc.30828","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10349_CR9","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/2159-8290.CD-21-0126","volume":"11","author":"P Horak","year":"2021","unstructured":"Horak, P., Heining, C., Kreutzfeldt, S., Hutter, B., Mock, A., H\u00fcllein, J., Fr\u00f6hlich, M., Uhrig, S., Jahn, A., Rump, A., Gieldon, L., M\u00f6hrmann, L., Hanf, D., Teleanu, V., Heilig, C. E., Lipka, D. B., Allg\u00e4uer, M., Ruhnke, L., La\u00dfmann, A., & Fr\u00f6hling, S. (2021). Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers. Cancer Discovery, 11(11), 2780\u20132795. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0126","journal-title":"Cancer Discovery"},{"issue":"2","key":"10349_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos, P. K., Taylor-Weiner, A., Manley, P. E., Jones, R. T., Dias-Santagata, D., Thorner, A. R., Rodriguez, F. J., Bernardo, L. A., Schubert, L., Sunkavalli, A., Shillingford, N., Calicchio, M. L., Lidov, H. G. W., Taha, H., Martinez-Lage, M., Santi, M., Storm, P. B., Lee, J. Y. K., Palmer, J. N., & Santagata, S. (2014). Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nature Genetics, 46(2), 161\u2013165. https:\/\/doi.org\/10.1038\/ng.2868","journal-title":"Nature Genetics"},{"issue":"35","key":"10349_CR11","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1200\/JCO.2018.78.9990","volume":"36","author":"T Kaley","year":"2018","unstructured":"Kaley, T., Touat, M., Subbiah, V., Hollebecque, A., Rodon, J., Lockhart, A. C., Keedy, V., Bielle, F., Hofheinz, R.-D., Joly, F., Blay, J.-Y., Chau, I., Puzanov, I., Raje, N. S., Wolf, J., DeAngelis, L. M., Makrutzki, M., Riehl, T., Pitcher, B., \u2026 Hyman, D. M. (2018). BRAF inhibition in BRAFV600-mutant gliomas: Results from the VE-BASKET study. Journal of Clinical Oncology, 36(35), 3477\u20133484. https:\/\/doi.org\/10.1200\/JCO.2018.78.9990","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10349_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/cns-2016-0034","volume":"6","author":"A Roque","year":"2017","unstructured":"Roque, A., & Odia, Y. (2017). BRAFV600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncology, 6(2), 95\u201399. https:\/\/doi.org\/10.2217\/cns-2016-0034","journal-title":"CNS Oncology"},{"issue":"11","key":"10349_CR13","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00701-017-3311-0","volume":"159","author":"E Rostami","year":"2017","unstructured":"Rostami, E., Witt Nystr\u00f6m, P., Libard, S., Wikstr\u00f6m, J., Casar-Borota, O., & Gudjonsson, O. (2017). Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochirurgica, 159(11), 2217\u20132221. https:\/\/doi.org\/10.1007\/s00701-017-3311-0","journal-title":"Acta Neurochirurgica"},{"issue":"6","key":"10349_CR14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007). Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell, 130(6), 1120\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2007.07.019","journal-title":"Cell"},{"issue":"1","key":"10349_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T., & Guan, K.-L. (2016). Mechanisms of Hippo pathway regulation. Genes & Development, 30(1), 1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115","journal-title":"Genes & Development"},{"issue":"1","key":"10349_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF\u03b2-TRCP. Genes & Development, 24(1), 72\u201385. https:\/\/doi.org\/10.1101\/gad.1843810","journal-title":"Genes & Development"},{"issue":"21","key":"10349_CR17","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z.-C., & Guan, K.-L. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & Development, 21(21), 2747\u20132761. https:\/\/doi.org\/10.1101\/gad.1602907","journal-title":"Genes & Development"},{"issue":"14","key":"10349_CR18","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., Lai, Z.-C., & Guan, K.-L. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes & Development, 22(14), 1962\u20131971. https:\/\/doi.org\/10.1101\/gad.1664408","journal-title":"Genes & Development"},{"issue":"8","key":"10349_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein, C., Bardet, A. F., Roma, G., Bergling, S., Clay, I., Ruchti, A., Agarinis, C., Schmelzle, T., Bouwmeester, T., Sch\u00fcbeler, D., & Bauer, A. (2015). YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genetics, 11(8), Article e1005465. https:\/\/doi.org\/10.1371\/journal.pgen.1005465","journal-title":"PLoS Genetics"},{"issue":"1","key":"10349_CR20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41467-022-28691-0","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma, S., Tang, T., Probst, G., Konradi, A., Jin, C., Li, F., Gutkind, J. S., Fu, X.-D., & Guan, K.-L. (2022). Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. Nature Communications, 13(1), 1061. https:\/\/doi.org\/10.1038\/s41467-022-28691-0","journal-title":"Nature Communications"},{"issue":"2","key":"10349_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","volume":"25","author":"S Jiao","year":"2014","unstructured":"Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., Wang, X., Guo, T., Li, P., Zhao, Y., Ji, H., Zhang, L., & Zhou, Z. (2014). A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell, 25(2), 166\u2013180. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.010","journal-title":"Cancer Cell"},{"issue":"3","key":"10349_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/cr.2014.10","volume":"24","author":"W Zhang","year":"2014","unstructured":"Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., Li, F., Chen, H., Zhou, Z., Zhang, L., & Ji, H. (2014). VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Research, 24(3), 331\u2013343. https:\/\/doi.org\/10.1038\/cr.2014.10","journal-title":"Cell Research"},{"issue":"6028","key":"10349_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011). Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science, 332(6028), 458\u2013461. https:\/\/doi.org\/10.1126\/science.1199010","journal-title":"Science"},{"issue":"23","key":"10349_CR24","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1101\/gad.1726608","volume":"22","author":"X Cao","year":"2008","unstructured":"Cao, X., Pfaff, S. L., & Gage, F. H. (2008). YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes & Development, 22(23), 3320\u20133334. https:\/\/doi.org\/10.1101\/gad.1726608","journal-title":"Genes & Development"},{"issue":"11","key":"10349_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110384","volume":"42","author":"W Fan","year":"2023","unstructured":"Fan, W., Jurado-Arjona, J., Alanis-Lobato, G., P\u00e9ron, S., Berger, C., Andrade-Navarro, M. A., Falk, S., & Berninger, B. (2023). The transcriptional co-activator Yap1 promotes adult hippocampal neural stem cell activation. EMBO Journal, 42(11), Article e110384. https:\/\/doi.org\/10.15252\/embj.2021110384","journal-title":"EMBO Journal"},{"issue":"13","key":"10349_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105770","volume":"40","author":"O Guillermin","year":"2021","unstructured":"Guillermin, O., Angelis, N., Sidor, C. M., Ridgway, R., Baulies, A., Kucharska, A., Antas, P., Rose, M. R., Cordero, J., Sansom, O., Li, V. S. W., & Thompson, B. J. (2021). Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration. EMBO Journal, 40(13), Article e105770. https:\/\/doi.org\/10.15252\/embj.2020105770","journal-title":"EMBO Journal"},{"issue":"10","key":"10349_CR27","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1242\/dev.133728","volume":"143","author":"A Elbediwy","year":"2016","unstructured":"Elbediwy, A., Vincent-Mistiaen, Z. I., Spencer-Dene, B., Stone, R. K., Boeing, S., Wculek, S. K., Cordero, J., Tan, E. H., Ridgway, R., Brunton, V. G., Sahai, E., Gerhardt, H., Behrens, A., Malanchi, I., Sansom, O. J., & Thompson, B. J. (2016). Integrin signalling regulates YAP and TAZ to control skin homeostasis. Development, 143(10), 1674\u20131687. https:\/\/doi.org\/10.1242\/dev.133728","journal-title":"Development"},{"issue":"9","key":"10349_CR28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.celrep.2016.02.021","volume":"14","author":"Y Deng","year":"2016","unstructured":"Deng, Y., Wu, A., Li, P., Li, G., Qin, L., Song, H., & Mak, K. K. (2016). Yap1 regulates multiple steps of chondrocyte differentiation during skeletal development and bone repair. Cell Reports, 14(9), 2224\u20132237. https:\/\/doi.org\/10.1016\/j.celrep.2016.02.021","journal-title":"Cell Reports"},{"issue":"7350","key":"10349_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., Elvassore, N., & Piccolo, S. (2011). Role of YAP\/TAZ in mechanotransduction. Nature, 474(7350), 179\u2013183. https:\/\/doi.org\/10.1038\/nature10137","journal-title":"Nature"},{"issue":"5","key":"10349_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s42255-024-01045-4","volume":"6","author":"S Choi","year":"2024","unstructured":"Choi, S., Kang, J.-G., Tran, Y. T. H., Jeong, S.-H., Park, K.-Y., Shin, H., Kim, Y. H., Park, M., Nahmgoong, H., Seol, T., Jeon, H., Kim, Y., Park, S., Kim, H., Kim, M.-S., Li, X., Bou Sleiman, M., Lee, E., Choi, J., \u2026 Suh, J. M. (2024). Hippo\u2013YAP\/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass. Nature Metabolism, 6(5), 847\u2013860. https:\/\/doi.org\/10.1038\/s42255-024-01045-4","journal-title":"Nature Metabolism"},{"issue":"1","key":"10349_CR31","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1038\/ncomms7048","volume":"6","author":"KI Watt","year":"2015","unstructured":"Watt, K. I., Turner, B. J., Hagg, A., Zhang, X., Davey, J. R., Qian, H., Beyer, C., Winbanks, C. E., Harvey, K. F., & Gregorevic, P. (2015). The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size. Nature Communications, 6(1), 6048. https:\/\/doi.org\/10.1038\/ncomms7048","journal-title":"Nature Communications"},{"issue":"1","key":"10349_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23240-7","volume":"12","author":"KI Watt","year":"2021","unstructured":"Watt, K. I., Henstridge, D. C., Ziemann, M., Sim, C. B., Montgomery, M. K., Samocha-Bonet, D., Parker, B. L., Dodd, G. T., Bond, S. T., Salmi, T. M., Lee, R. S., Thomson, R. E., Hagg, A., Davey, J. R., Qian, H., Koopman, R., El-Osta, A., Greenfield, J. R., Watt, M. J., \u2026 Gregorevic, P. (2021). Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease. Nature Communications, 12(1), Article 2887. https:\/\/doi.org\/10.1038\/s41467-021-23240-7","journal-title":"Nature Communications"},{"issue":"7","key":"10349_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","volume":"151","author":"L Azzolin","year":"2012","unstructured":"Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2012). Role of TAZ as mediator of Wnt signaling. Cell, 151(7), 1443\u20131456. https:\/\/doi.org\/10.1016\/j.cell.2012.11.027","journal-title":"Cell"},{"issue":"1","key":"10349_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., Fassina, A., Cordenonsi, M., & Piccolo, S. (2014). YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell, 158(1), 157\u2013170. https:\/\/doi.org\/10.1016\/j.cell.2014.06.013","journal-title":"Cell"},{"issue":"2","key":"10349_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-017-0244-8","volume":"9","author":"F Deng","year":"2018","unstructured":"Deng, F., Peng, L., Li, Z., Tan, G., Liang, E., Chen, S., Zhao, X., & Zhi, F. (2018). YAP triggers the Wnt\/\u03b2-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death & Disease, 9(2), 153. https:\/\/doi.org\/10.1038\/s41419-017-0244-8","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10349_CR36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/emboj.2011.487","volume":"31","author":"M Imajo","year":"2012","unstructured":"Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A., & Nishida, E. (2012). A molecular mechanism that links Hippo signalling to the inhibition of Wnt\/\u03b2-catenin signalling. The EMBO Journal, 31(5), 1109\u20131122. https:\/\/doi.org\/10.1038\/emboj.2011.487","journal-title":"The EMBO Journal"},{"issue":"12","key":"10349_CR37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ncb2615","volume":"14","author":"K Tumaneng","year":"2012","unstructured":"Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012). YAP mediates crosstalk between the Hippo and PI(3)K\u2013TOR pathways by suppressing PTEN via miR-29. Nature Cell Biology, 14(12), 1322\u20131329. https:\/\/doi.org\/10.1038\/ncb2615","journal-title":"Nature Cell Biology"},{"issue":"21","key":"10349_CR38","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1038\/sj.emboj.7601872","volume":"26","author":"B Cinar","year":"2007","unstructured":"Cinar, B., Fang, P.-K., Lutchman, M., Di Vizio, D., Adam, R. M., Pavlova, N., Rubin, M. A., Yelick, P. C., & Freeman, M. R. (2007). The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. The EMBO Journal, 26(21), 4523\u20134534. https:\/\/doi.org\/10.1038\/sj.emboj.7601872","journal-title":"The EMBO Journal"},{"issue":"7","key":"10349_CR39","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.1216462110","volume":"110","author":"R Fan","year":"2013","unstructured":"Fan, R., Kim, N.-G., & Gumbiner, B. M. (2013). Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proceedings of the National Academy of Sciences of the United States of America, 110(7), 2569\u20132574. https:\/\/doi.org\/10.1073\/pnas.1216462110","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10349_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.21.634138","author":"KC Garcia","year":"2025","unstructured":"Garcia, K. C., Khan, A. A., Ghosh, K., Sinha, S., Scalora, N., DeWane, G., Fullenkamp, C., Merritt, N., Drebot, Y., Yu, S., Leidinger, M., Henry, M. D., Breheny, P., Chimenti, M. S., & Tanas, M. R. (2025). PI3K regulates TAZ\/YAP and mTORC1 axes that can be synergistically targeted. bioRxiv. https:\/\/doi.org\/10.1101\/2025.01.21.634138","journal-title":"bioRxiv"},{"issue":"1","key":"10349_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13578-019-0362-3","volume":"9","author":"A Vall\u00e9e","year":"2019","unstructured":"Vall\u00e9e, A., & Lecarpentier, Y. (2019). TGF-\u03b2 in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell & Bioscience, 9(1), 98. https:\/\/doi.org\/10.1186\/s13578-019-0362-3","journal-title":"Cell & Bioscience"},{"issue":"7","key":"10349_CR42","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B. M., Dembowy, J., Yaffe, M. B., Zandstra, P. W., & Wrana, J. L. (2008). TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nature Cell Biology, 10(7), 837\u2013848. https:\/\/doi.org\/10.1038\/ncb1748","journal-title":"Nature Cell Biology"},{"issue":"18","key":"10349_CR43","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200860","volume":"149","author":"IM Mart\u00ednez Traverso","year":"2022","unstructured":"Mart\u00ednez Traverso, I. M., Steimle, J. D., Zhao, X., Wang, J., & Martin, J. F. (2022). LATS1\/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation. Development, 149(18), Article dev200860. https:\/\/doi.org\/10.1242\/dev.200860","journal-title":"Development"},{"issue":"4","key":"10349_CR44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"F-X Yu","year":"2012","unstructured":"Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X.-D., Mills, G. B., & Guan, K.-L. (2012). Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell, 150(4), 780\u2013791. https:\/\/doi.org\/10.1016\/j.cell.2012.06.037","journal-title":"Cell"},{"issue":"17","key":"10349_CR45","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1242\/dev.125807","volume":"142","author":"LJ Manderfield","year":"2015","unstructured":"Manderfield, L. J., Aghajanian, H., Engleka, K. A., Lim, L. Y., Liu, F., Jain, R., Li, L., Olson, E. N., & Epstein, J. A. (2015). Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest. Development, 142(17), 2962\u20132971. https:\/\/doi.org\/10.1242\/dev.125807","journal-title":"Development"},{"issue":"1","key":"10349_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI88486","volume":"127","author":"W Kim","year":"2017","unstructured":"Kim, W., Khan, S. K., Gvozdenovic-Jeremic, J., Kim, Y., Dahlman, J., Kim, H., Park, O., Ishitani, T., Jho, E., Gao, B., & Yang, Y. (2017). Hippo signaling interactions with Wnt\/\u03b2-catenin and Notch signaling repress liver tumorigenesis. The Journal of Clinical Investigation, 127(1), 137\u2013152. https:\/\/doi.org\/10.1172\/JCI88486","journal-title":"The Journal of Clinical Investigation"},{"key":"10349_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-022-00151-6","volume":"12","author":"C Tang","year":"2023","unstructured":"Tang, C., Wang, J., Yao, M., Ji, X., Shi, W., Xu, C., Zeng, L.-H., & Wu, X. (2023). Hippo signaling activates Hedgehog signaling by Taz-driven Gli3 processing. Cell Regeneration, 12, Article 3. https:\/\/doi.org\/10.1186\/s13619-022-00151-6","journal-title":"Cell Regeneration"},{"issue":"599","key":"10349_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb2233","volume":"13","author":"Q Cong","year":"2021","unstructured":"Cong, Q., Liu, Y., Zhou, T., Zhou, Y., Xu, R., Cheng, C., Chung, H. S., Yan, M., Zhou, H., Liao, Z., Gao, B., Bocobo, G. A., Covington, T. A., Song, H. J., Su, P., Yu, P. B., & Yang, Y. (2021). A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification. Science Translational Medicine, 13(599), Article eabb2233. https:\/\/doi.org\/10.1126\/scitranslmed.abb2233","journal-title":"Science Translational Medicine"},{"issue":"8","key":"10349_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183178","volume":"12","author":"B Akladios","year":"2017","unstructured":"Akladios, B., Reinoso, V. M., Cain, J. E., Wang, T., Lambie, D. L., Watkins, D. N., & Beverdam, A. (2017). Positive regulatory interactions between YAP and Hedgehog signalling in skin homeostasis and BCC development in mouse skin in vivo. PLoS One, 12(8), Article e0183178. https:\/\/doi.org\/10.1371\/journal.pone.0183178","journal-title":"PLoS One"},{"issue":"7","key":"10349_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ncb2986","volume":"16","author":"D Romano","year":"2014","unstructured":"Romano, D., Nguyen, L. K., Matallanas, D., Halasz, M., Doherty, C., Kholodenko, B. N., & Kolch, W. (2014). Protein interaction switches coordinate Raf-1 and MST2\/Hippo signalling. Nature Cell Biology, 16(7), 673\u2013684. https:\/\/doi.org\/10.1038\/ncb2986","journal-title":"Nature Cell Biology"},{"issue":"6","key":"10349_CR51","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.18632\/oncotarget.2974","volume":"6","author":"B You","year":"2015","unstructured":"You, B., Yang, Y.-L., Xu, Z., Dai, Y., Liu, S., Mao, J.-H., Tetsu, O., Li, H., Jablons, D. M., & You, L. (2015). Inhibition of ERK1\/2 down-regulates the Hippo\/YAP signaling pathway in human NSCLC cells. Oncotarget, 6(6), 4357\u20134368. https:\/\/doi.org\/10.18632\/oncotarget.2974","journal-title":"Oncotarget"},{"issue":"1","key":"10349_CR52","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s42003-025-09009-4","volume":"8","author":"S Sayedyahossein","year":"2025","unstructured":"Sayedyahossein, S., Babu Sait, M. R., Li, Z., Banerjee, R., Tran, A., Thines, L., Karimi, M., Bahmani, M., Mishan, N., Borzou, P., Hassan, S. A., & Sacks, D. B. (2025). KSR1 is a scaffold for the Hippo signaling pathway. Communications Biology, 8(1), 1725. https:\/\/doi.org\/10.1038\/s42003-025-09009-4","journal-title":"Communications Biology"},{"issue":"4","key":"10349_CR53","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","volume":"308","author":"F Liu","year":"2015","unstructured":"Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinkovi\u0107, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., Rosas, I. O., Fredenburgh, L. E., Feghali-Bostwick, C., Varelas, X., Tager, A. M., & Tschumperlin, D. J. (2015). Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology, 308(4), L344\u2013L357. https:\/\/doi.org\/10.1152\/ajplung.00300.2014","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10349_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146243","volume":"7","author":"X He","year":"2022","unstructured":"He, X., Tolosa, M. F., Zhang, T., Goru, S. K., Ulloa Severino, L., Misra, P. S., McEvoy, C. M., Caldwell, L., Szeto, S. G., Gao, F., Chen, X., Atin, C., Ki, V., Vukosa, N., Hu, C., Zhang, J., Yip, C., Krizova, A., Wrana, J. L., & Yuen, D. A. (2022). Myofibroblast YAP\/TAZ activation is a key step in organ fibrogenesis. JCI Insight, 7(4), Article e146243. https:\/\/doi.org\/10.1172\/jci.insight.146243","journal-title":"JCI Insight"},{"issue":"804","key":"10349_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adq3852","volume":"17","author":"X He","year":"2025","unstructured":"He, X., Ballestas, E. R., Zeng, L., Zhang, T., McEvoy, C. M., Misra, P. S., Ki, V., Apostol, A., Wong, J. S., Meliambro, K., Ray, J., De Cos, M., Melica, M. E., Romagnani, P., Feng, Y., Krizova, A., How, I., Rosales, I. A., Colvin, R. B., & Yuen, D. A. (2025). Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans. Science Translational Medicine, 17(804), Article eadq3852. https:\/\/doi.org\/10.1126\/scitranslmed.adq3852","journal-title":"Science Translational Medicine"},{"issue":"7","key":"10349_CR56","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1073\/pnas.1116136109","volume":"109","author":"A von Gise","year":"2012","unstructured":"von Gise, A., Lin, Z., Schlegelmilch, K., Honor, L. B., Pan, G. M., Buck, J. N., Ma, Q., Ishiwata, T., Zhou, B., Camargo, F. D., & Pu, W. T. (2012). YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proceedings of the National Academy of Sciences of the United States of America, 109(7), 2394\u20132399. https:\/\/doi.org\/10.1073\/pnas.1116136109","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"21","key":"10349_CR57","doi-asserted-by":"publisher","DOI":"10.1242\/dev.187187","volume":"147","author":"HK Vanyai","year":"2020","unstructured":"Vanyai, H. K., Prin, F., Guillermin, O., Marzook, B., Boeing, S., Howson, A., Saunders, R. E., Snoeks, T., Howell, M., Mohun, T. J., & Thompson, B. J. (2020). Control of skeletal morphogenesis by the Hippo-YAP\/TAZ pathway. Development, 147(21), Article dev187187. https:\/\/doi.org\/10.1242\/dev.187187","journal-title":"Development"},{"issue":"29","key":"10349_CR58","doi-asserted-by":"publisher","first-page":"12066","DOI":"10.1073\/pnas.1300894110","volume":"110","author":"JK Lee","year":"2013","unstructured":"Lee, J. K., Shin, J. H., Hwang, S. G., Gwag, B. J., McKee, A. C., Lee, J., Kowall, N. W., Ryu, H., Lim, D.-S., & Choi, E.-J. (2013). MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS. Proceedings of the National Academy of Sciences of the United States of America, 110(29), 12066\u201312071. https:\/\/doi.org\/10.1073\/pnas.1300894110","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10349_CR59","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"L Zender","year":"2006","unstructured":"Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., & Lowe, S. W. (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 125(7), 1253\u20131267. https:\/\/doi.org\/10.1016\/j.cell.2006.05.030","journal-title":"Cell"},{"issue":"4","key":"10349_CR60","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., Daidone, M. G., Dupont, S., Basso, G., Bicciato, S., & Piccolo, S. (2011). The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell, 147(4), 759\u2013772. https:\/\/doi.org\/10.1016\/j.cell.2011.09.048","journal-title":"Cell"},{"issue":"10","key":"10349_CR61","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1245\/s10434-025-17657-3","volume":"32","author":"M Oshi","year":"2025","unstructured":"Oshi, M., Ghasemi, F., Yamada, A., Yan, L., Zhang, J., Abrams, S. I., Endo, I., & Takabe, K. (2025). Activated Hippo pathway is associated with a worse response to trastuzumab and worse survival in HER2-positive breast cancer. Annals of Surgical Oncology, 32(10), 7959\u20137969. https:\/\/doi.org\/10.1245\/s10434-025-17657-3","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"10349_CR62","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., & Seshagiri, S. (2016). Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nature Genetics, 48(4), 407\u2013416. https:\/\/doi.org\/10.1038\/ng.3520","journal-title":"Nature Genetics"},{"key":"10349_CR63","unstructured":"American Association for Cancer Research. (n.d.). LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Research. https:\/\/aacrjournals.org\/cancerres\/article\/71\/3\/873\/572605\/LATS2-Is-a-Tumor-Suppressor-Gene-of-Malignant (accessed January 11, 2026)"},{"issue":"4","key":"10349_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12573","volume":"21","author":"L Jiang","year":"2021","unstructured":"Jiang, L., Zhang, J., Xu, Q., Wang, B., Yao, Y., Sun, L., Wang, X., Zhou, D., Gao, L., Song, S., & Zhu, X. (2021). YAP promotes the proliferation and migration of colorectal cancer cells through the GLUT3\/AMPK signaling pathway. Oncology Letters, 21(4), 1\u20139. https:\/\/doi.org\/10.3892\/ol.2021.12573","journal-title":"Oncology Letters"},{"issue":"23","key":"10349_CR65","doi-asserted-by":"publisher","first-page":"37154","DOI":"10.18632\/oncotarget.16209","volume":"8","author":"C Yang","year":"2017","unstructured":"Yang, C., Tan, J., Zhu, J., Wang, S., & Wei, G. (2017). YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Oncotarget, 8(23), 37154\u201337163. https:\/\/doi.org\/10.18632\/oncotarget.16209","journal-title":"Oncotarget"},{"issue":"1","key":"10349_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cncr.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse, K. R., & Maris, J. M. (2016). Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer, 122(1), 20\u201333. https:\/\/doi.org\/10.1002\/cncr.29706","journal-title":"Cancer"},{"issue":"5","key":"10349_CR67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/2159-8290.CD-16-0861","volume":"8","author":"P Rajbhandari","year":"2018","unstructured":"Rajbhandari, P., Lopez, G., Capdevila, C., Salvatori, B., Yu, J., Rodriguez-Barrueco, R., Martinez, D., Yarmarkovich, M., Weichert-Leahey, N., Abraham, B. J., Alvarez, M. J., Iyer, A., Harenza, J. L., Oldridge, D., De Preter, K., Koster, J., Asgharzadeh, S., Seeger, R. C., & Maris, J. M. (2018). Cross-cohort analysis identifies a TEAD4 \u2194 MYCN positive-feedback loop as the core regulatory element of high-risk neuroblastoma. Cancer Discovery, 8(5), 582\u2013599. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0861","journal-title":"Cancer Discovery"},{"issue":"5","key":"10349_CR68","first-page":"842","volume":"57","author":"C Raffel","year":"1997","unstructured":"Raffel, C., Jenkins, R. B., Frederick, L., Hebrink, D., Alderete, B., Fults, D. W., & James, C. D. (1997). Sporadic medulloblastomas contain PTCH mutations. Cancer Research, 57(5), 842\u2013845.","journal-title":"Cancer Research"},{"issue":"5329","key":"10349_CR69","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.277.5329.1109","volume":"277","author":"LV Goodrich","year":"1997","unstructured":"Goodrich, L. V., Milenkovi\u0107, L., Higgins, K. M., & Scott, M. P. (1997). Altered neural cell fates and medulloblastoma in mouse Patched mutants. Science, 277(5329), 1109\u20131113. https:\/\/doi.org\/10.1126\/science.277.5329.1109","journal-title":"Science"},{"issue":"23","key":"10349_CR70","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1101\/gad.1824509","volume":"23","author":"A Fernandez-L","year":"2009","unstructured":"Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009). YAP1 is amplified and up-regulated in Hedgehog-associated medulloblastomas and mediates Sonic Hedgehog-driven neural precursor proliferation. Genes & Development, 23(23), 2729\u20132741. https:\/\/doi.org\/10.1101\/gad.1824509","journal-title":"Genes & Development"},{"issue":"1","key":"10349_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00165516","volume":"29","author":"JP Provias","year":"1996","unstructured":"Provias, J. P., & Becker, L. E. (1996). Cellular and molecular pathology of medulloblastoma. Journal of Neuro-Oncology, 29(1), 35\u201343. https:\/\/doi.org\/10.1007\/BF00165516","journal-title":"Journal of Neuro-Oncology"},{"issue":"24","key":"10349_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246249","volume":"13","author":"GAV Cruzeiro","year":"2021","unstructured":"Cruzeiro, G. A. V., Magalh\u00e3es, TdeA., Sousa, G. R., Silva, R. B., Junior, CAOdeB., Chagas, P. F., Queiroz, RGdeP., Scrideli, C. A., Tone, L. G., & Valera, E. T. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13(24), Article 6249. https:\/\/doi.org\/10.3390\/cancers13246249","journal-title":"Cancers"},{"key":"10349_CR73","doi-asserted-by":"publisher","unstructured":"Myogenesis and rhabdomyosarcoma: The Jekyll and Hyde of skeletal muscle. (2011). In Current Topics in Developmental Biology (Vol. 94, pp. 197\u2013234). Academic Press. https:\/\/doi.org\/10.1016\/B978-0-12-380916-2.00007-3","DOI":"10.1016\/B978-0-12-380916-2.00007-3"},{"issue":"2","key":"10349_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccr.2014.05.029","volume":"26","author":"AM Tremblay","year":"2014","unstructured":"Tremblay, A. M., Missiaglia, E., Galli, G. G., Hettmer, S., Urcia, R., Carrara, M., Judson, R. N., Thway, K., Nadal, G., Selfe, J. L., Murray, G., Calogero, R. A., De Bari, C., Zammit, P. S., Delorenzi, M., Wagers, A. J., Shipley, J., Wackerhage, H., & Camargo, F. D. (2014). The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation. Cancer Cell, 26(2), 273\u2013287. https:\/\/doi.org\/10.1016\/j.ccr.2014.05.029","journal-title":"Cancer Cell"},{"issue":"2","key":"10349_CR75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jnci\/48.2.313","volume":"48","author":"AG Knudson Jr","year":"1972","unstructured":"Knudson, A. G., Jr., & Strons, L. C. (1972). Mutation and cancer: A model for Wilms\u2019 tumor of the kidney. Journal of the National Cancer Institute, 48(2), 313\u2013324. https:\/\/doi.org\/10.1093\/jnci\/48.2.313","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10349_CR76","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ncb2828","volume":"15","author":"A Das","year":"2013","unstructured":"Das, A., Tanigawa, S., Karner, C. M., Xin, M., Lum, L., Chen, C., Olson, E. N., Perantoni, A. O., & Carroll, T. J. (2013). Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. Nature Cell Biology, 15(9), 1035\u20131044. https:\/\/doi.org\/10.1038\/ncb2828","journal-title":"Nature Cell Biology"},{"issue":"2","key":"10349_CR77","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/pbc.24788","volume":"61","author":"AJ Murphy","year":"2014","unstructured":"Murphy, A. J., Pierce, J., de Caestecker, C., Libes, J., Neblett, D., de Caestecker, M., Perantoni, A. O., Tanigawa, S., Anderson, J. R., Dome, J. S., Das, A., Carroll, T. J., & Lovvorn, H. N. (2014). Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. Pediatric Blood & Cancer, 61(2), 198\u2013205. https:\/\/doi.org\/10.1002\/pbc.24788","journal-title":"Pediatric Blood & Cancer"},{"key":"10349_CR78","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2147\/CMAR.S297842","volume":"13","author":"X He","year":"2021","unstructured":"He, X., Luo, X., Dong, J., Deng, X., Liu, F., & Wei, G. (2021). Long non-coding RNA XIST promotes Wilms tumor progression through the miR-194-5p\/YAP axis. Cancer Management and Research, 13, 3171\u20133180. https:\/\/doi.org\/10.2147\/CMAR.S297842","journal-title":"Cancer Management and Research"},{"issue":"11","key":"10349_CR79","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","volume":"4","author":"F Tirode","year":"2014","unstructured":"Tirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., et al. (2014). Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discovery, 4(11), 1342\u20131353. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0622","journal-title":"Cancer Discovery"},{"issue":"4","key":"10349_CR80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/path.5379","volume":"250","author":"P Rodr\u00edguez-N\u00fa\u00f1ez","year":"2020","unstructured":"Rodr\u00edguez-N\u00fa\u00f1ez, P., Romero-P\u00e9rez, L., Amaral, A. T., Puerto-Camacho, P., Jord\u00e1n, C., Marcilla, D., et al. (2020). Hippo pathway effectors YAP1\/TAZ induce an EWS\u2013FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma. Journal of Pathology, 250(4), 374\u2013386. https:\/\/doi.org\/10.1002\/path.5379","journal-title":"Journal of Pathology"},{"key":"10349_CR81","doi-asserted-by":"publisher","unstructured":"Read, R., Jimenez Macias, L., Oh, S., Hu, Z., Yin, K., Sele, N., et al. (2025). The YAP\/TAZ-TEAD axis promotes tumor stem cell functionality and cellular heterogeneity in pediatric high-grade gliomas. Neuro-Oncology, 27(Supplement_3), iii36. https:\/\/doi.org\/10.1093\/neuonc\/noaf193.111","DOI":"10.1093\/neuonc\/noaf193.111"},{"issue":"6","key":"10349_CR82","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202401057","volume":"223","author":"D Kim","year":"2024","unstructured":"Kim, D., Olson, J. M., & Cooper, J. A. (2024). N-cadherin dynamically regulates pediatric glioma cell migration in complex environments. Journal of Cell Biology, 223(6), Article e202401057. https:\/\/doi.org\/10.1083\/jcb.202401057","journal-title":"Journal of Cell Biology"},{"issue":"4","key":"10349_CR83","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.21037\/tp-20-285","volume":"10","author":"LL Resende","year":"2021","unstructured":"Resende, L. L., & Alves, C. A. P. F. (2021). Imaging of brain tumors in children: The basics\u2014a narrative review. Translational Pediatrics, 10(4), 1138\u20131168. https:\/\/doi.org\/10.21037\/tp-20-285","journal-title":"Translational Pediatrics"},{"issue":"13","key":"10349_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133468","volume":"15","author":"RB Mokhtari","year":"2023","unstructured":"Mokhtari, R. B., Ashayeri, N., Baghaie, L., Sambi, M., Satari, K., Baluch, N., et al. (2023). The Hippo pathway effectors YAP\/TAZ-TEAD oncoproteins as emerging therapeutic targets in the tumor microenvironment. Cancers, 15(13), Article 3468. https:\/\/doi.org\/10.3390\/cancers15133468","journal-title":"Cancers"},{"issue":"22","key":"10349_CR85","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-15-0411","volume":"21","author":"A Sebio","year":"2015","unstructured":"Sebio, A., & Lenz, H.-J. (2015). Molecular pathways: Hippo signaling, a critical tumor suppressor. Clinical Cancer Research, 21(22), 5002\u20135007. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0411","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10349_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ccell.2020.06.004","volume":"38","author":"J Gojo","year":"2020","unstructured":"Gojo, J., Englinger, B., Jiang, L., H\u00fcbner, J. M., Shaw, M. L., Hack, O. A., et al. (2020). Single-cell RNA-seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma. Cancer Cell, 38(1), 44\u201359. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.004","journal-title":"Cancer Cell"},{"issue":"12","key":"10349_CR87","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","volume":"51","author":"S Jessa","year":"2019","unstructured":"Jessa, S., et al. (2019). Stalled developmental programs at the root of pediatric brain tumors. Nature Genetics, 51(12), 1702\u20131713. https:\/\/doi.org\/10.1038\/s41588-019-0531-7","journal-title":"Nature Genetics"},{"issue":"2","key":"10349_CR88","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s43018-020-00150-z","volume":"2","author":"M Castellan","year":"2021","unstructured":"Castellan, M., et al. (2021). Single-cell analyses reveal YAP\/TAZ as regulators of stemness and cell plasticity in glioblastoma. Nature Cancer, 2(2), 174\u2013188. https:\/\/doi.org\/10.1038\/s43018-020-00150-z","journal-title":"Nature Cancer"},{"key":"10349_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1238684","volume":"14","author":"L Cao","year":"2023","unstructured":"Cao, L., et al. (2023). The unique immune ecosystems in pediatric brain tumors: Integrating single-cell and bulk RNA sequencing. Frontiers in Immunology, 14, Article 1238684. https:\/\/doi.org\/10.3389\/fimmu.2023.1238684","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10349_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108023","volume":"32","author":"AE Gillen","year":"2020","unstructured":"Gillen, A. E., Riemondy, K. A., Amani, V., Griesinger, A. M., Gilani, A., Venkataraman, S., et al. (2020). Single-cell RNA sequencing of childhood ependymoma reveals neoplastic cell subpopulations that impact molecular classification and etiology. Cell Reports, 32(6), Article 108023. https:\/\/doi.org\/10.1016\/j.celrep.2020.108023","journal-title":"Cell Reports"},{"issue":"1","key":"10349_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1242\/dmm.026500","volume":"10","author":"M Mayrhofer","year":"2017","unstructured":"Mayrhofer, M., Gourain, V., Reischl, M., Affaticati, P., Jenett, A., Joly, J.-S., et al. (2017). A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK\/PI3K induced malignant growth. Disease Models & Mechanisms, 10(1), 15\u201328. https:\/\/doi.org\/10.1242\/dmm.026500","journal-title":"Disease Models & Mechanisms"},{"issue":"9","key":"10349_CR92","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.neo.2021.07.005","volume":"23","author":"B Holmes","year":"2021","unstructured":"Holmes, B., Benavides-Serrato, A., Saunders, J. T., Kumar, S., Nishimura, R. N., & Gera, J. (2021). mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasion. Neoplasia, 23(9), 951\u2013965. https:\/\/doi.org\/10.1016\/j.neo.2021.07.005","journal-title":"Neoplasia"},{"key":"10349_CR93","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-017-0606-1","volume":"36","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Pan, P., Wang, Z., Zhang, Y., Xie, P., Geng, D., et al. (2017). \u03b2-Catenin-mediated YAP signaling promotes human glioma growth. Journal of Experimental & Clinical Cancer Research, 36, 136. https:\/\/doi.org\/10.1186\/s13046-017-0606-1","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"2","key":"10349_CR94","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3892\/etm.2018.6322","volume":"16","author":"B Hao","year":"2018","unstructured":"Hao, B., Chen, X., & Cao, Y. (2018). Yes-associated protein 1 promotes the metastasis of U251 glioma cells by upregulating Jagged-1 expression and activating the Notch pathway. Experimental and Therapeutic Medicine, 16(2), 1411\u20131416. https:\/\/doi.org\/10.3892\/etm.2018.6322","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10349_CR95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","volume":"38","author":"L Yi","year":"2019","unstructured":"Yi, L., Zhou, X., Li, T., Liu, P., Hai, L., Tong, L., et al. (2019). Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via CXCL12\/CXCR4. Journal of Experimental & Clinical Cancer Research, 38, 339. https:\/\/doi.org\/10.1186\/s13046-019-1319-4","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"6","key":"10349_CR96","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1158\/0008-5472.CAN-04-1890","volume":"65","author":"BW Purow","year":"2005","unstructured":"Purow, B. W., Haque, R. M., Noel, M. W., Su, Q., Burdick, M. J., Lee, J., et al. (2005). Expression of Notch-1 and its ligands, Delta-Like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Research, 65(6), 2353\u20132363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1890","journal-title":"Cancer Research"},{"issue":"8","key":"10349_CR97","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jso.21851","volume":"103","author":"J Li","year":"2011","unstructured":"Li, J., Cui, Y., Gao, G., Zhao, Z., Zhang, H., & Wang, X. (2011). Notch1 is an independent prognostic factor for patients with glioma. Journal of Surgical Oncology, 103(8), 813\u2013817. https:\/\/doi.org\/10.1002\/jso.21851","journal-title":"Journal of Surgical Oncology"},{"issue":"8","key":"10349_CR98","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/emboj\/18.8.2196","volume":"18","author":"T Ohtsuka","year":"1999","unstructured":"Ohtsuka, T., Ishibashi, M., Gradwohl, G., Nakanishi, S., Guillemot, F., & Kageyama, R. (1999). Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation. EMBO Journal, 18(8), 2196\u20132207. https:\/\/doi.org\/10.1093\/emboj\/18.8.2196","journal-title":"EMBO Journal"},{"issue":"7015","key":"10349_CR99","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396\u2013401. https:\/\/doi.org\/10.1038\/nature03128","journal-title":"Nature"},{"issue":"16","key":"10349_CR100","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani, V., Yang, Y., Schubert, M. C., Reyhan, E., Tetzlaff, S. K., Wi\u00dfmann, N., Botz, M., Soyka, S. J., Beretta, C. A., Pramatarov, R. L., Fankhauser, L., Garofano, L., Freudenberg, A., Wagner, J., Tanev, D. I., Ratliff, M., Xie, R., Kessler, T., Hoffmann, D. C., & Winkler, F. (2022). Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell, 185(16), 2899\u20132917. https:\/\/doi.org\/10.1016\/j.cell.2022.06.054","journal-title":"Cell"},{"issue":"6386","key":"10349_CR101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin, M. G., Tirosh, I., Hovestadt, V., Shaw, M. L., Escalante, L. E., Mathewson, N. D., & Bernstein, B. E. (2018). Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science, 360(6386), 331\u2013335. https:\/\/doi.org\/10.1126\/science.aao4750","journal-title":"Science"},{"issue":"25","key":"10349_CR102","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.2036535100","volume":"100","author":"HD Hemmati","year":"2003","unstructured":"Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proceedings of the National Academy of Sciences of the United States of America, 100(25), 15178\u201315183. https:\/\/doi.org\/10.1073\/pnas.2036535100","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"27","key":"10349_CR103","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1038\/s41388-021-01878-3","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Wang, Y., Zhou, D., Wang, K., Wang, X., Jiang, Y., Zhao, M., Yu, R., & Zhou, X. (2021). Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair. Oncogene, 40(27), 4580\u20134591. https:\/\/doi.org\/10.1038\/s41388-021-01878-3","journal-title":"Oncogene"},{"issue":"4","key":"10349_CR104","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbrc.2015.05.115","volume":"463","author":"T Tian","year":"2015","unstructured":"Tian, T., Li, A., Lu, H., Luo, R., Zhang, M., & Li, Z. (2015). TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells. Biochemical and Biophysical Research Communications, 463(4), 638\u2013643. https:\/\/doi.org\/10.1016\/j.bbrc.2015.05.115","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10349_CR105","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., & Piccolo, S. (2015). Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nature Cell Biology, 17(9), 1218\u20131227. https:\/\/doi.org\/10.1038\/ncb3216","journal-title":"Nature Cell Biology"},{"issue":"5","key":"10349_CR106","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.celrep.2015.12.104","volume":"14","author":"X Liu","year":"2016","unstructured":"Liu, X., et al. (2016). Tead and AP1 coordinate transcription and motility. Cell Reports, 14(5), 1169\u20131180. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.104","journal-title":"Cell Reports"},{"key":"10349_CR107","doi-asserted-by":"publisher","unstructured":"Rodriguez-N\u00fa\u00f1ez, P., Romero-P\u00e9rez, L., Amaral, A. T., Puerto-Camacho, P., Jord\u00e1n, C., Marcilla, D., \u2026 D\u00edaz-Mart\u00edn, J. (2011). PI3K\/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathologica, 121, 407\u2013420. https:\/\/doi.org\/10.1007\/s00401-010-0784-9","DOI":"10.1007\/s00401-010-0784-9"},{"key":"10349_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9357","volume":"6","author":"Z Meng","year":"2015","unstructured":"Meng, Z., et al. (2015). MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nature Communications, 6, Article 8357. https:\/\/doi.org\/10.1038\/ncomms9357","journal-title":"Nature Communications"},{"issue":"1","key":"10349_CR109","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1038\/s41467-022-31399-w","volume":"13","author":"MA Vittoria","year":"2022","unstructured":"Vittoria, M. A., Kingston, N., Kotynkova, K., Xia, E., Hong, R., Huang, L., & Ganem, N. J. (2022). Inactivation of the Hippo tumor suppressor pathway promotes melanoma. Nature Communications, 13(1), 3732. https:\/\/doi.org\/10.1038\/s41467-022-31399-w","journal-title":"Nature Communications"},{"issue":"8","key":"10349_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082042","volume":"12","author":"T Azad","year":"2020","unstructured":"Azad, T., Rezaei, R., Surendran, A., Singaravelu, R., Boulton, S., Dave, J., Bell, J. C., & Ilkow, C. S. (2020). Hippo signaling pathway as a central mediator of receptors tyrosine kinases (RTKs) in tumorigenesis. Cancers, 12(8), Article 2042. https:\/\/doi.org\/10.3390\/cancers12082042","journal-title":"Cancers"},{"issue":"15","key":"10349_CR111","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41388-018-0609-1","volume":"38","author":"X Yang","year":"2019","unstructured":"Yang, X., Shen, H., Buckley, B., Chen, Y., Yang, N., Mussell, A. L., & Zhang, J. (2019). NTRK1 is a positive regulator of YAP oncogenic function. Oncogene, 38(15), 2778\u20132787. https:\/\/doi.org\/10.1038\/s41388-018-0609-1","journal-title":"Oncogene"},{"issue":"5","key":"10349_CR112","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/cancers9050044","volume":"9","author":"C Xiang","year":"2017","unstructured":"Xiang, C., Chen, J., & Fu, P. (2017). HGF\/Met signaling in cancer invasion: The impact on cytoskeleton remodeling. Cancers, 9(5), 44. https:\/\/doi.org\/10.3390\/cancers9050044","journal-title":"Cancers"},{"key":"10349_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/82_2010_56","volume":"346","author":"E Castellano","year":"2010","unstructured":"Castellano, E., & Downward, J. (2010). Role of RAS in the regulation of PI 3-kinase. In Current Topics in Microbiology and Immunology, 346, 143\u2013169. https:\/\/doi.org\/10.1007\/82_2010_56","journal-title":"In Current Topics in Microbiology and Immunology"},{"key":"10349_CR114","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","volume":"54","author":"BK Wu","year":"2022","unstructured":"Wu, B. K., Mei, S. C., Chen, E. H., et al. (2022). YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Nature Genetics, 54, 1202\u20131213. https:\/\/doi.org\/10.1038\/s41588-022-01119-7","journal-title":"Nature Genetics"},{"issue":"12","key":"10349_CR115","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-15-1144","volume":"76","author":"W Guerrant","year":"2016","unstructured":"Guerrant, W., Kota, S., Troutman, S., Mandati, V., Fallahi, M., Stemmer-Rachamimov, A., & Kissil, J. L. (2016). YAP mediates tumorigenesis in neurofibromatosis type 2 by promoting cell survival and proliferation through a COX-2\u2013EGFR signaling axis. Cancer Research, 76(12), 3507\u20133519. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1144","journal-title":"Cancer Research"},{"issue":"12","key":"10349_CR116","first-page":"2719","volume":"9","author":"S Saab","year":"2019","unstructured":"Saab, S., Chang, O. S., Nagaoka, K., Hung, M. C., & Yamaguchi, H. (2019). The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors. American Journal of Cancer Research, 9(12), 2719\u20132729.","journal-title":"American Journal of Cancer Research"},{"key":"10349_CR117","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s13311-022-01249-0","volume":"19","author":"H Smith","year":"2022","unstructured":"Smith, H., Wadhwani, N., & Horbinski, C. (2022). Major features of the 2021 WHO classification of CNS tumors. Neurotherapeutics, 19, 1691\u20131704. https:\/\/doi.org\/10.1007\/s13311-022-01249-0","journal-title":"Neurotherapeutics"},{"key":"10349_CR118","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41419-018-0302-x","volume":"9","author":"H Xia","year":"2018","unstructured":"Xia, H., Dai, X., Yu, H., et al. (2018). EGFR\u2013PI3K\u2013PDK1 pathway regulates YAP signaling in hepatocellular carcinoma. Cell Death & Disease, 9, 269. https:\/\/doi.org\/10.1038\/s41419-018-0302-x","journal-title":"Cell Death & Disease"},{"issue":"20","key":"10349_CR119","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1101\/gad.301184.117","volume":"31","author":"O Croci","year":"2017","unstructured":"Croci, O., De Fazio, S., Biagioni, E., Donato, E., Caganova, M., Curti, L., Biagioni, F., & Campaner, S. (2017). Transcriptional integration of mitogenic and mechanical signals by Myc and YAP. Genes & Development, 31(20), 2017\u20132022. https:\/\/doi.org\/10.1101\/gad.301184.117","journal-title":"Genes & Development"},{"issue":"22","key":"10349_CR120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201883119","volume":"119","author":"K Kraft","year":"2022","unstructured":"Kraft, K., Yost, K. E., Murphy, S. E., Magg, A., Long, Y., Corces, M. R., & Chang, H. Y. (2022). Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation. Proceedings of the National Academy of Sciences of the United States of America, 119(22), Article e2201883119. https:\/\/doi.org\/10.1073\/pnas.2201883119","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"15\u201316","key":"10349_CR121","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1101\/gad.326066.119","volume":"33","author":"AP Bracken","year":"2019","unstructured":"Bracken, A. P., Brien, G. L., & Verrijzer, C. P. (2019). Dangerous liaisons: Interplay between SWI\/SNF, NuRD, and Polycomb in chromatin regulation and cancer. Genes & Development, 33(15\u201316), 936\u2013959. https:\/\/doi.org\/10.1101\/gad.326066.119","journal-title":"Genes & Development"},{"issue":"5","key":"10349_CR122","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/cells8050502","volume":"8","author":"RE Hillmer","year":"2019","unstructured":"Hillmer, R. E., & Link, B. A. (2019). The roles of Hippo signaling transducers Yap and Taz in chromatin remodeling. Cells, 8(5), 502. https:\/\/doi.org\/10.3390\/cells8050502","journal-title":"Cells"},{"issue":"6","key":"10349_CR123","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.molcel.2019.01.019","volume":"73","author":"IY Lee","year":"2019","unstructured":"Lee, I. Y., Lim, J. M., Cho, H., Kim, E., Kim, Y., Oh, H. K., Yang, W. S., Roh, K. H., Park, H. W., Mo, J. S., Yoon, J. H., Song, H. K., & Choi, E. J. (2019). MST1 negatively regulates TNF\u03b1-induced NF-\u03baB signaling through modulating LUBAC activity. Molecular Cell, 73(6), 1138\u20131149. https:\/\/doi.org\/10.1016\/j.molcel.2019.01.019","journal-title":"Molecular Cell"},{"key":"10349_CR124","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cellsig.2017.01.006","volume":"32","author":"A Martincuks","year":"2017","unstructured":"Martincuks, A., K\u00fcster, A., Schmitz-Van de Leur, H., Komorowski, M., & M\u00fcller-Newen, G. (2017). Nuclear translocation of STAT3 and NF-\u03baB are independent of each other but NF-\u03baB supports expression and activation of STAT3. Cellular Signalling, 32, 36\u201347. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.006","journal-title":"Cellular Signalling"},{"issue":"7","key":"10349_CR125","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/biomedicines10071704","volume":"10","author":"PC Hsu","year":"2022","unstructured":"Hsu, P. C., Li, J. M., & Yang, C. T. (2022). Forced overexpression of STAT3 activates YAP expression and increases invasion and proliferation of small cell lung cancer cells. Biomedicines, 10(7), 1704. https:\/\/doi.org\/10.3390\/biomedicines10071704","journal-title":"Biomedicines"},{"key":"10349_CR126","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41588-021-00819-w","volume":"53","author":"NV Dharia","year":"2021","unstructured":"Dharia, N. V., Kugener, G., Guenther, L. M., et al. (2021). A first-generation pediatric cancer dependency map. Nature Genetics, 53, 529\u2013538. https:\/\/doi.org\/10.1038\/s41588-021-00819-w","journal-title":"Nature Genetics"},{"issue":"8","key":"10349_CR127","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/ph17081048","volume":"17","author":"H Guo","year":"2024","unstructured":"Guo, H., Xu, X., Zhang, J., Du, Y., Yang, X., He, Z., Zhao, L., Liang, T., & Guo, L. (2024). The pivotal role of preclinical animal models in anti-cancer drug discovery and personalized cancer therapy strategies. Pharmaceuticals, 17(8), 1048. https:\/\/doi.org\/10.3390\/ph17081048","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10349_CR128","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-020-02171-5","volume":"140","author":"KS Smith","year":"2020","unstructured":"Smith, K. S., Xu, K., Mercer, K. S., Boop, F., Klimo, P., DeCupyere, M., Grenet, J., Robinson, S., Dunphy, P., Baker, S. J., Ellison, D. W., Merchant, T. E., Upadhyaya, S. A., Gajjar, A., Wu, G., Orr, B. A., Robinson, G. W., Northcott, P. A., & Roussel, M. F. (2020). Patient-derived orthotopic xenografts of pediatric brain tumors: A St. Jude resource. Acta Neuropathologica, 140(2), 209\u2013225. https:\/\/doi.org\/10.1007\/s00401-020-02171-5","journal-title":"Jude resource. Acta Neuropathologica"},{"key":"10349_CR129","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202318199","volume":"15","author":"C Lago","year":"2023","unstructured":"Lago, C., Federico, A., Leva, G., et al. (2023). Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments. EMBO Molecular Medicine, 15, Article EMMM202318199. https:\/\/doi.org\/10.15252\/emmm.202318199","journal-title":"EMBO Molecular Medicine"},{"key":"10349_CR130","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827a","volume":"21","author":"C Grasso","year":"2015","unstructured":"Grasso, C., Tang, Y., Truffaux, N., et al. (2015). Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature Medicine, 21, 827. https:\/\/doi.org\/10.1038\/nm0715-827a","journal-title":"Nature Medicine"},{"issue":"10","key":"10349_CR131","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.3390\/cells10102715","volume":"10","author":"ER Barry","year":"2021","unstructured":"Barry, E. R., Simov, V., Valtingojer, I., & Venier, O. (2021). Recent therapeutic approaches to modulate the Hippo pathway in oncology and regenerative medicine. Cells, 10(10), 2715. https:\/\/doi.org\/10.3390\/cells10102715","journal-title":"Cells"},{"issue":"4","key":"10349_CR132","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nchembio.2036","volume":"12","author":"P Chan","year":"2016","unstructured":"Chan, P., Han, X., Zheng, B., DeRan, M., Yu, J., Jarugumilli, G. K., Deng, H., Pan, D., Luo, X., & Wu, X. (2016). Autopalmitoylation of TEAD proteins regulates transcriptional output of Hippo pathway. Nature Chemical Biology, 12(4), 282\u2013289. https:\/\/doi.org\/10.1038\/nchembio.2036","journal-title":"Nature Chemical Biology"},{"issue":"359","key":"10349_CR133","doi-asserted-by":"publisher","DOI":"10.1126\/stke.3592006re14","volume":"2006","author":"MD Resh","year":"2006","unstructured":"Resh, M. D. (2006). Palmitoylation of ligands, receptors, and intracellular signaling molecules. Science Signaling, 2006(359), Article re14. https:\/\/doi.org\/10.1126\/stke.3592006re14","journal-title":"Science Signaling"},{"issue":"6","key":"10349_CR134","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","volume":"20","author":"TT Tang","year":"2021","unstructured":"Tang, T. T., Konradi, A. W., Feng, Y., Peng, X., Ma, M., Li, J., Yu, F.-X., Guan, K.-L., & Post, L. (2021). Small molecule inhibitors of TEAD auto-palmitoylation selectively inhibit proliferation and tumor growth of NF2-deficient mesothelioma. Molecular Cancer Therapeutics, 20(6), 986\u2013998. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0717","journal-title":"Molecular Cancer Therapeutics"},{"key":"10349_CR135","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Hu, L., Tao, Z., Jarugumilli, G. K., Erb, H., Singh, A., Li, Q., Cotton, J. L., Greninger, P., Egan, R. K., Ip, Y. T., Benes, C. H., Che, J., Mao, J., & Wu, X. (2022). Pharmacological blockade of TEAD\u2013YAP reveals its therapeutic limitation in cancer cells. Nature Communications, 13, 6744. https:\/\/doi.org\/10.1038\/s41467-022-34559-0","journal-title":"Nature Communications"},{"key":"10349_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1021823","author":"A Gridnev","year":"2022","unstructured":"Gridnev, A., Maity, S., & Misra, J. R. (2022). Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2022.1021823","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10349_CR137","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1101\/gad.1865810","volume":"24","author":"Z Li","year":"2010","unstructured":"Li, Z., Zhao, B., Wang, P., Chen, F., Dong, Z., Yang, H., Guan, K.-L., & Xu, Y. (2010). Structural insights into the YAP and TEAD complex. Genes & Development, 24(3), 235\u2013240. https:\/\/doi.org\/10.1101\/gad.1865810","journal-title":"Genes & Development"},{"issue":"16","key":"10349_CR138","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1021\/acs.jpcb.3c07073","volume":"128","author":"KR Mills","year":"2024","unstructured":"Mills, K. R., Misra, J., & Torabifard, H. (2024). Allosteric modulation of the YAP\/TAZ\u2013TEAD interaction by palmitoylation and small-molecule inhibitors. The Journal of Physical Chemistry B, 128(16), 3795\u20133806. https:\/\/doi.org\/10.1021\/acs.jpcb.3c07073","journal-title":"The Journal of Physical Chemistry B"},{"issue":"16","key":"10349_CR139","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.3390\/cancers13164246","volume":"13","author":"J Kim","year":"2021","unstructured":"Kim, J., Lim, H., Moon, S., Cho, S. Y., Park, J. H., Park, H. W., & No, K. T. (2021). Hot spot analysis of YAP\u2013TEAD protein\u2013protein interaction using the fragment molecular orbital method and its application for inhibitor discovery. Cancers, 13(16), 4246. https:\/\/doi.org\/10.3390\/cancers13164246","journal-title":"Cancers"},{"key":"10349_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118330","volume":"302","author":"F Chen","year":"2026","unstructured":"Chen, F., Su, J., Liu, Y., Zhang, Z., Li, S., Yuan, Y., & Lai, J. (2026). Targeting YAP\/TAZ\u2013TEAD and their protein\u2013protein interaction for precision cancer therapy. European Journal of Medicinal Chemistry, 302, Article 118330. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118330","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"9","key":"10349_CR141","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/ml500160m","volume":"5","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z., Lin, Z., Zhou, Z., Shen, H. C., Yan, S. F., Mayweg, A. V., Xu, Z., Qin, N., Wong, J. C., Rong, Y., Fry, D. C., & Hu, T. (2014). Structure-based design and synthesis of potent cyclic peptides inhibiting the YAP\u2013TEAD protein\u2013protein interaction. ACS Medicinal Chemistry Letters, 5(9), 993\u2013998. https:\/\/doi.org\/10.1021\/ml500160m","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"12","key":"10349_CR142","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012). Genetic and pharmacological disruption of the TEAD\u2013YAP complex suppresses the oncogenic activity of YAP. Genes & Development, 26(12), 1300\u20131305. https:\/\/doi.org\/10.1101\/gad.192856.112","journal-title":"Genes & Development"},{"key":"10349_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.557429","volume":"11","author":"C Wei","year":"2020","unstructured":"Wei, C., & Li, X. (2020). The role of photoactivated and non-photoactivated verteporfin on tumor. Frontiers in Pharmacology, 11, Article 557429. https:\/\/doi.org\/10.3389\/fphar.2020.557429","journal-title":"Frontiers in Pharmacology"},{"key":"10349_CR144","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.1038\/s41598-017-07632-8","volume":"7","author":"A Al-Moujahed","year":"2017","unstructured":"Al-Moujahed, A., Brodowska, K., Stryjewski, T. P., Efstathiou, N. E., Vasilikos, I., Cichy, J., Miller, J. W., Gragoudas, E., & Vavvas, D. G. (2017). Verteporfin inhibits growth of human glioma in vitro without light activation. Scientific Reports, 7, 7602. https:\/\/doi.org\/10.1038\/s41598-017-07632-8","journal-title":"Scientific Reports"},{"issue":"9","key":"10349_CR145","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/antiox12091681","volume":"12","author":"L Kang","year":"2023","unstructured":"Kang, L., Yi, J., Lau, C.-W., He, L., Chen, Q., Xu, S., Li, J., Xia, Y., Zhang, Y., Huang, Y., & Wang, L. (2023). AMPK-dependent YAP inhibition mediates the protective effect of formin against obesity-associated endothelial dysfunction and inflammation. Antioxidants, 12(9), 1681. https:\/\/doi.org\/10.3390\/antiox12091681","journal-title":"Antioxidants"},{"issue":"4","key":"10349_CR146","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1165\/rcmb.2019-0296OC","volume":"62","author":"DM Santos","year":"2020","unstructured":"Santos, D. M., Pantano, L., Pronzati, G., et al. (2020). Screening for YAP inhibitors identifies statins as modulators of fibrosis. American Journal of Respiratory Cell and Molecular Biology, 62(4), 479\u2013492. https:\/\/doi.org\/10.1165\/rcmb.2019-0296OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2","key":"10349_CR147","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jb\/mvr063","volume":"150","author":"Y Bao","year":"2011","unstructured":"Bao, Y., Nakagawa, K., Yang, Z., et al. (2011). A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on YAP-dependent gene transcription. Journal of Biochemistry, 150(2), 199\u2013208. https:\/\/doi.org\/10.1093\/jb\/mvr063","journal-title":"Journal of Biochemistry"},{"issue":"11","key":"10349_CR148","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1002\/jcp.30459","volume":"236","author":"KM Choi","year":"2021","unstructured":"Choi, K. M., Haak, A. J., Diaz Espinosa, A. M., Cummins, K. A., Link, P. A., Aravamudhan, A., Wood, D. K., & Tschumperlin, D. J. (2021). GPCR-mediated YAP\/TAZ inactivation in fibroblasts via EPAC1\/2, RAP2C, and MAP4K7. Journal of Cellular Physiology, 236(11), 7759\u20137774. https:\/\/doi.org\/10.1002\/jcp.30459","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"10349_CR149","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/1878-0261.12667","volume":"14","author":"S Song","year":"2020","unstructured":"Song, S., Li, Y., Xu, Y., Ma, L., Pool Pizzi, M., Jin, J., Scott, A. W., Huo, L., Wang, Y., Lee, J. H., Bhutani, M. S., Weston, B., Shanbhag, N. D., Johnson, R. L., & Ajani, J. A. (2020). Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Molecular Oncology, 14(6), 1410\u20131426. https:\/\/doi.org\/10.1002\/1878-0261.12667","journal-title":"Molecular Oncology"},{"issue":"3","key":"10349_CR150","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.celrep.2015.09.014","volume":"13","author":"W Wang","year":"2015","unstructured":"Wang, W., Li, N., Li, X., Tran, M. K., Han, X., & Chen, J. (2015). Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins. Cell Reports, 13(3), 524\u2013532. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.014","journal-title":"Cell Reports"},{"issue":"6","key":"10349_CR151","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3892\/ijo.2013.2121","volume":"43","author":"XJ Li","year":"2013","unstructured":"Li, X. J., Leem, S.-H., Park, M. H., & Kim, S. M. (2013). Regulation of YAP through an Akt-dependent process by 3,3\u2032-diindolylmethane in human colon cancer cells. International Journal of Oncology, 43(6), 1992\u20131998. https:\/\/doi.org\/10.3892\/ijo.2013.2121","journal-title":"International Journal of Oncology"},{"issue":"12","key":"10349_CR152","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","volume":"31","author":"TA Yap","year":"2025","unstructured":"Yap, T. A., et al. (2025). YAP\/TEAD inhibitor VT3989 in solid tumors: A phase 1\/2 trial. Nature Medicine, 31(12), 4281\u20134290. https:\/\/doi.org\/10.1038\/s41591-025-04029-3","journal-title":"Nature Medicine"},{"key":"10349_CR153","doi-asserted-by":"publisher","unstructured":"A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. (2022). Journal of Clinical Oncology. https:\/\/ascopubs.org\/doi\/https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.TPS3168","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168"},{"key":"10349_CR154","doi-asserted-by":"publisher","unstructured":"Tolcher, A. W., Lakhani, N. J., McKean, M., Malek, K. S., Torkamboor, S., Sun, Y., Ghosh, C., & Kakar, R. (2022). A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. Journal of Clinical Oncology, 40(16_suppl), Article TPS3168.\u00a0https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.TPS3168","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168"},{"key":"10349_CR155","doi-asserted-by":"publisher","unstructured":"Garralda, E., Florescu, M., Aerts, J. G., Yoshida, T., Postel-Vinay, S., Dagogo-Jack, I., Krebs, M. G., Metzenmacher, M., John, T., Kindler, H. L., Altan, M., Bankel, L., Shepard, D., Wainberg, Z. A. A., Duca, M., Lam, V. K., Parhiala, K., Altzerinakou, M.-A., Faris, J., & Santoro, A. (2025). 919O A first-in-human study of oral IAG933 in adult patients with advanced mesothelioma and other solid tumours. Annals of Oncology, 36(Suppl. 5), S562.\u00a0https:\/\/doi.org\/10.1016\/j.annonc.2025.08.1488","DOI":"10.1016\/j.annonc.2025.08.1488"},{"key":"10349_CR156","unstructured":"Ionis Pharmaceuticals, Inc., & M.D. Anderson Cancer Center. (2021). A study of ION537 in patients with molecularly selected advanced solid tumors (ClinicalTrials.gov Identifier NCT04659096). U.S. National Library of Medicine.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT04659096"},{"key":"10349_CR157","unstructured":"Victorian Cancer Trials Link. (2024). IK930-001: A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. https:\/\/trials.cancervic.org.au\/details\/vctl_nct05228015"},{"issue":"2","key":"10349_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12762","volume":"48","author":"D Strepkos","year":"2022","unstructured":"Strepkos, D., Markouli, M., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2022). Emerging roles for the YAP\/TAZ transcriptional regulators in brain tumour pathology and targeting options. Neuropathology and Applied Neurobiology, 48(2), Article e12762. https:\/\/doi.org\/10.1111\/nan.12762","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"5","key":"10349_CR159","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/jcmm.17212","volume":"26","author":"I Zoi","year":"2022","unstructured":"Zoi, I., Gargalionis, A. N., Papavassiliou, K. A., Nasiri-Ansari, N., Piperi, C., Basdra, E. K., & Papavassiliou, A. G. (2022). Polycystin-1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro. Journal of Cellular and Molecular Medicine, 26(5), 1699\u20131709. https:\/\/doi.org\/10.1111\/jcmm.17212","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10349_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107287","volume":"206","author":"KA Papavassiliou","year":"2024","unstructured":"Papavassiliou, K. A., Gargalionis, A. N., & Papavassiliou, A. G. (2024). Direct YAP\/TAZ\u2013TEAD inhibitor paves the way toward realizing cancer mechanomedicine. Pharmacological Research, 206, Article 107287. https:\/\/doi.org\/10.1016\/j.phrs.2024.107287","journal-title":"Pharmacological Research"},{"issue":"5","key":"10349_CR161","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K., Jeong, K. J., Tsang, Y. H., Moreno, D., Bhavana, V. H., Peng, X., Ge, Z., Chen, H., Li, J., Chen, Z., Zhang, H., Han, L., Du, D., Creighton, C. J., \u2026 Liang, H. (2018). Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Reports, 25(5), 1304\u20131317. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.001","journal-title":"Cell Reports"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10349-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:12:26Z","timestamp":1781331146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":161,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["10349"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10349-8","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"40"}}